| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/05/1995 | DE4405841C1 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals |
| 01/05/1995 | DE4318186A1 Retrovirus from HIV group and use thereof |
| 01/05/1995 | CA2166104A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | CA2165786A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165461A1 Compositions and diagnostic methods using monoclonal antibodies against cd44v6 |
| 01/05/1995 | CA2165202A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use |
| 01/05/1995 | CA2165053A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631616A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 01/04/1995 | EP0631507A1 Selective alteration of antibody immunogenicity |
| 01/04/1995 | EP0631506A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 01/04/1995 | EP0631502A1 Lymphocyte activity regulation by hla peptides |
| 01/04/1995 | EP0631501A1 Glycosylation-mediated inhibition of factor x |
| 01/04/1995 | EP0404935B1 Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1 |
| 01/03/1995 | US5378815 Process for indirect targeted immunocytolysis |
| 01/03/1995 | US5378814 Hepatitis delta viral polypeptides |
| 01/03/1995 | US5378812 Human antibodies which specifically bind to lipopolysaccharide determinants of some pseudomonas serotypes and inhibit these bacteria, for prevention and treatment of infections |
| 01/03/1995 | US5378805 Immunoreactive HTLV-I/II ENV and POL peptides |
| 01/03/1995 | US5378615 Process for the production of vaccine for prevention of Pasteurella haemolytica pneumonia in bovine |
| 01/03/1995 | US5378467 Cell-free Marek's disease virus vaccine |
| 01/03/1995 | US5378457 Immunology, genetic engineering |
| 01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
| 01/02/1995 | CA2125344A1 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| 12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/28/1994 | EP0630407A1 Anti-viral fusion peptides |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630385A1 Potent peptide for stimulation of cytotoxic t lymphocytes specific for the hiv-1 envelope |
| 12/28/1994 | EP0630260A1 Polysaccharide-protein conjugates |
| 12/28/1994 | EP0630258A1 Vaccine for susceptible hosts against nonadapted parasites |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity |
| 12/28/1994 | EP0248887B1 Cell-free t cell antigen receptor and its clinical utilities |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/27/1994 | US5376370 Vaccine for malaria |
| 12/27/1994 | US5376369 Vaccine adjuvant |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029720A1 Leukocyte adhesion assay |
| 12/22/1994 | WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | WO1994029469A2 Plasmids suitable for gene therapy |
| 12/22/1994 | WO1994029459A1 Stress proteins and uses therefor |
| 12/22/1994 | WO1994029451A2 Humanised antibodies |
| 12/22/1994 | WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 12/22/1994 | WO1994029448A1 Dna and protein coded for thereby |
| 12/22/1994 | WO1994029446A2 Intracellular binding proteins and use thereof |
| 12/22/1994 | WO1994029439A1 High yielding influenza viruses |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029351A3 Antibodies |
| 12/22/1994 | WO1994029351A2 Antibodies |
| 12/22/1994 | WO1994029350A2 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 12/22/1994 | WO1994029348A2 Production of antibody fragments |
| 12/22/1994 | WO1994029347A1 Antibody fragments in therapy |
| 12/22/1994 | WO1994029346A1 IDENTIFICATION OF THE ADHESIN GENE FROM $i(M. PIRUM) |
| 12/22/1994 | WO1994029339A1 Tandem synthetic hiv-1 peptides |
| 12/22/1994 | WO1994029334A1 Immunoglobulin g concentrate for therapeutical use and method for producing same |
| 12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | WO1994029332A1 Coiled-coil stem loop templates |
| 12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
| 12/22/1994 | WO1994029329A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| 12/22/1994 | WO1994028934A1 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies |
| 12/22/1994 | WO1994028932A1 Immunoglobulin infusion in xenotransplantation |
| 12/22/1994 | WO1994028931A1 Methods for treating inflammatory disorders |
| 12/22/1994 | WO1994028930A1 Malaria recombinant poxvirus vaccine |
| 12/22/1994 | WO1994028929A1 Hiv envelope polypeptides |
| 12/22/1994 | WO1994028928A1 Novel attenuated pseudomonas aeruginosa strains |
| 12/22/1994 | WO1994028927A1 Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide |
| 12/22/1994 | WO1994028925A1 Vaccine containing a serine protease |
| 12/22/1994 | WO1994028920A1 Synthetic peptide inhibitors of hiv transmission |
| 12/22/1994 | WO1994028916A1 Release and mobilisation of haematopoietic cells |
| 12/22/1994 | WO1994028915A1 Hiv retrovirus infection inhibitor capable of interacting with cd26 receptor |
| 12/22/1994 | WO1994028873A1 Novel therapeutic drug delivery systems |
| 12/22/1994 | WO1994025596A3 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
| 12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 12/22/1994 | DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms |
| 12/22/1994 | CA2168124A1 Malaria recombinant poxvirus vaccine |
| 12/22/1994 | CA2164946A1 High yielding influenza viruses |
| 12/22/1994 | CA2164843A1 Novel therapeutic drug delivery systems |
| 12/22/1994 | CA2164701A1 Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide |
| 12/22/1994 | CA2164518A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | CA2164505A1 Hiv envelope polypeptides |
| 12/22/1994 | CA2164298A1 Stress proteins and uses therefor |
| 12/22/1994 | CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | CA2163905A1 Inhibiting protein interactions |
| 12/22/1994 | CA2163345A1 Antibodies |
| 12/22/1994 | CA2163344A1 Humanised antibodies |
| 12/22/1994 | CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 12/22/1994 | CA2161349A1 Immunoglobulin infusion in xenotransplantation |
| 12/21/1994 | EP0629696A1 Recombinant DNA-derived bordetella toxin subunit analogs |
| 12/21/1994 | EP0629350A1 Milk protein hydrolysates |
| 12/21/1994 | EP0629292A1 Method for making a preconjugate |
| 12/21/1994 | EP0629240A1 Altered antibodies, products and processes relating thereto |
| 12/21/1994 | EP0629238A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 12/21/1994 | EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME |
| 12/21/1994 | EP0629131A1 ANTIGENS PROTECTIVE AGAINST $i(ECHINOCOCCUS GRANULOSUS) INFECTION AND VACCINES CONTAINING SUCH ANTIGENS |
| 12/21/1994 | EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 12/21/1994 | EP0551275B1 Non-a non-b sequences |
| 12/21/1994 | EP0424518B1 Utilisation of adenyl cyclase as vaccine against bordetella |